© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Early 19th-century chemists pulled scopolamine from plants in the nightshade family, especially those eerie Datura and Atropa varieties that dotted both European and South American landscapes. Folk medicine healers trusted these plants for “mad dog” fevers and as sedatives, a practice that trickled into hospital corridors as physicians started to seek reliable anesthetics and antiemetics. Scopolamine rose in the medical world through trial, error, and plenty of mishaps, gaining a permanent spot in medicine cabinets after World War 1. Surgeons told stories of women in “twilight sleep” after childbirth or soldiers quieted before surgery. These days, the rigorous regulations and purity standards that companies follow trace their roots back to the unpredictable, sometimes dangerous uses in the pre-modern era.
Scopolamine hydrobromide comes as a powder, usually white or off-white and slightly bitter if you’ve ever tasted a tablet by accident. Its job in hospitals has never changed much: manage motion sickness, handle surgical nausea, help Parkinson’s patients when other methods stumble. Transdermal patches and liquid injections offer doctors a range of delivery routes, but behind the packaging sits the same alkaloid core. Manufacturing runs lean and tightly controlled, with pharmaceutical labs focusing on purification since even slight impurities can spell disaster for nervous system drugs. Some companies have begun packaging it in single-use vials that keep away contamination—a far cry from the broad-application botanicals that defined its early life.
Scopolamine hydrobromide dissolves easily in water and ethanol thanks to its salt form, and it holds up under typical shelf storage, only breaking down when sunlight and moisture poke through. Its molecular formula, C17H21NO4·HBr·3H2O, signals its hydrated nature, which has caused shelf-life headaches for pharmacists in humid climates. It’s not volatile, but like any active alkaloid, demands respect during handling and storage. The crystalline form almost guarantees steady dosing—something patients and doctors both depend on. That consistency remains critical when scopolamine is given by injection or patch, because a slip in dose can throw off a patient’s levels dramatically.
Manufacturers stamp packaging with dose, batch, storage instructions, and expiration dates in sharp detail, all set by tough international rules. United States Pharmacopoeia and European Pharmacopeia play referee, holding companies to particle size and dissolution rates so doctors treating sea-sick tourists in the Caribbean or cancer patients in old city hospitals get the same product every time. Dosage forms stay clearly marked, especially since transdermal patches deliver drugs slowly, needing warnings and careful patient instructions. Child-resistant packaging and anti-tamper seals now sit on pharmacy shelves, showing how industry has responded to a century of misuse and mistakes.
Production starts in greenhouses or fields, with the cultivation of Duboisia and Scopolia. Once harvested, plants get cut, shredded, soaked in ethanol, and then filtered, washing the crude alkaloid mixture into extraction tanks. Chemists then convert base scopolamine into a hydrohalide salt, usually using hydrobromic acid. Filtration, purification by crystallization, then more washing and drying, get rid of plant gunk and trace toxins. Final products go through strict quality-control labs, where professionals check everything from particle size to indications of degradation. Sometimes, companies screen for specific isotopes to make sure counterfeiters have no chance to intervene.
With a tropane ring and ester function, scopolamine hydrobromide serves as a clean slate for modification. Some research teams swap out esters, turning the molecule into different analogs that might offer more selectivity or milder side effects. Reactivity centers mostly on the epoxide bridge, which lets chemists nudge the pharmacological properties. Studies out of academic labs have shown promise in branching out to longer-acting antiemetics or developing forms that pass the blood-brain barrier with more reliability. Chemical stability in the presence of common buffers and excipients stays high, which keeps it a favorite for both pharmaceutical modifications and academic curiosity.
Pharmacists and doctors know it under trade names like Hyoscine Hydrobromide, Scopoderm, or Transderm Scop, depending on region and delivery method. The base compound gets registered in chemical catalogs as L-Hyoscine Hydrobromide, Scopine Tropate Hydrobromide, or 6-beta,7-beta-Epoxy-3-alpha-tropanediol Tropate Hydrobromide. Retail labels can obscure its plant-based roots, so professional medical training always includes a crash course on its naming conventions to avoid hospital errors. In the research sphere, academic chemists stick to IUPAC or CAS numbers, keeping literature searches consistent and transparent.
Handling scopolamine hydrobromide calls for gloves, eye protection, and good ventilation, straight from personal experience in the lab. Tiny doses can twist cognition, making it critical for pharmacists to measure triple-check quantities before compounding. Storage demands tight lids and dry cabinets, especially in shared hospital dispensaries. Regulatory bodies keep their eyes on inventory logs, and hospitals enforce double-count systems for all controlled alkaloids. Doctors run frequent training for nurses after a few too many accidental transdermal exposures led to confusion and memory loss among staff. Public health records show that overdoses, both accidental and intentional, drop when strict inventory systems pair with regular staff education.
Motion sickness and postoperative nausea remain its main gigs, but scopolamine plays a powerful hand in end-of-life and palliative care. Doctors struggling to manage secretions and comfort in advanced cancer or neurological diseases often reach for it after more benign anticholinergics fail. Research hospitals have pushed into studying its effects on depression and even dissociative states, though enthusiasm stays tempered by the risk of delirium. In the illicit world, stories of misuse for “zombie drugs” in South America highlight the ongoing need for careful distribution and public education. Unlike some old alkaloids, scopolamine hasn’t faded from the clinical scene because no other compound fills its narrow but vital roles quite as well.
After decades of stable pharmaceutical use, modern research fixates on delivery technology. Scientists design patches that level off drug release, aim for micro-implantable pumps, or explore nasal sprays for urgent settings. Synthetic chemists synthesize novel analogs, trying to dodge the classic anticholinergic side effects while keeping the central action strong. Collaboration with computational chemists speeds the search for new tropane derivatives by using simulations rather than slow trial-and-error. Some researchers lean toward combining scopolamine with other drugs to offer new treatments for chronic nausea, or to ease severe withdrawal in addiction recovery. Regulatory agencies now encourage transparency, enforcing data sharing on adverse effects in both trials and follow-up studies.
The line between a therapeutic dose and a toxic hit sits razor-thin. Animal studies run heavy, charting which concentrations send nervous system symptoms spiraling from sedation to outright delirium or death. Emergency room physicians know to look for rapid pupil dilation and confusion in accidental pediatric exposures. Chronic studies in hospital settings have led to updated warning labels after vulnerable elders fell into delirium, pushing the industry to champion lower starting doses and required follow-up visits. In my own work with prescription oversight, I’ve seen that real-world toxicity drops as soon as digital records flag frequent renewals or suspicious usage. These lessons from bedside to bench pay off in fewer ER visits and safer medication logs.
New delivery platforms and precision medicine look like the next frontier. Formulators bet on microneedle arrays and bio-adhesive films that promise fewer side effects and steady absorption for travelers, cancer survivors, or elders with swallowing trouble. Biotech startups chase receptor-selective analogs for more potent Parkinson’s therapy or even as psychiatric interventions where classic drugs fail. On the regulatory front, stricter verification and traceability standards keep supply chains tight, shooing away both fakes and unsafe imports. From hospital tests to university projects, the prospects ride on collaboration and smarter oversight so the next century of this alkaloid’s story can deliver the promise without repeating the mistakes of its complicated past.
Plenty of people know the misery of seasickness, a rough bus ride, or a spinning roller coaster. The queasy feeling can stick around long after the fun is over. For years, doctors have handed out scopolamine hydrobromide to travelers and patients who struggle with these symptoms. This medication comes in patches or tablets that block certain nerve signals, and those signals send waves of nausea to the brain.
During a cruise I took years ago, I watched passengers slap on these patches behind their ears. Some had mild complaints of dry mouth, but most reported far less nausea and vomiting. In hospitals, I’ve also seen scopolamine offered before surgeries, since anesthesia and post-surgical painkillers can leave folks feeling sick for hours.
Scopolamine hydrobromide isn’t just for motion sickness. Doctors might prescribe it for people who have trouble with drooling, especially those with Parkinson’s disease or certain neurological conditions. It works by drying out secretions, and this makes daily life a bit easier for folks who are already handling bigger health struggles.
End-of-life care brings complicated symptoms. Patients who can’t swallow sometimes develop thick secretions, which can cause noisy breathing. Nursing teams sometimes use scopolamine for this reason, aiming to bring more comfort in the final days.
No medication comes without risks. Scopolamine can cause drowsiness, dry mouth, blurry vision, or confusion, especially in older adults. I’ve seen seniors get disoriented after using it, at home or in care facilities. Some folks tolerate these side effects; others find them too much.
Scopolamine shouldn’t be used carelessly. People with glaucoma, urinary retention, or certain heart conditions need careful guidance from their doctor before trying it. The Food and Drug Administration classifies scopolamine as a prescription medication, and using more than directed won’t make the symptoms vanish faster — it just creates new problems.
Doctors want effective solutions for nausea, but not everyone needs the same treatment. Options like ginger, acupressure bands, or changing the route of travel (sitting toward the center of the ship or bus) sometimes work for mild cases. For people who get sick from anesthesia, newer medications with fewer side effects also exist, like ondansetron. These choices don’t cause dry mouth or confusion, so they fit better for older people or those prone to side effects.
People taking scopolamine patches or pills should keep an open dialogue with their care team. A doctor or pharmacist can offer advice about timing, what to expect, and how to handle dry mouth. Storing these patches and tablets away from kids matters, since an accidental dose could cause trouble in a child or pet.
Good care calls for education. Before travel, after surgery, or during an illness, knowing options and risks helps everyone make better health decisions. From what I’ve seen, scopolamine hydrobromide does its job well when the right person takes it, with guidance about how much and how long to use it.
Few drugs help motion sickness the way scopolamine patches do. After placing that patch behind the ear, the effect sneaks up within hours. People usually reach for this medication while hopping onto a cruise or preparing for tricky travel. Most of us want to skip the seasick feeling but often forget what else comes with the relief. Over the years, I’ve seen people trade one problem for another. Scopolamine changes how your body feels in small but noticeable ways.
Dry mouth is the most common side effect. Moisture disappears. Some folks say it feels like cotton stuck to your lips. Water rarely cuts through it — that thirst lingers throughout the day. This matches up with what medical research shows. The US National Library of Medicine lists dry mouth in more than 60% of users. Sipping on water or chewing sugar-free gum can ease that dryness, though nothing works as well as stopping the patch.
After a few hours with the patch, eyesight gets fuzzy. Scopolamine affects the muscles that help eyes focus. For some people, reading a book or glancing at a phone grows difficult. As someone who wears glasses for every task, adding blurry vision on top feels like extra punishment. Not everyone cares if a day goes by in a soft blur, but driving or using heavy machines can grow dangerous. That’s why, in my clinic, I warn patients not to operate a car after starting the patch.
Drowsiness creeps in for many people. Some sleep unusually well; others feel groggy during the afternoon, even without doing much. Low mental energy follows, making schoolwork or important meetings a real drag. Studies show that about one out of every five users experiences some combination of tiredness, headache, or confusion. This risk climbs higher in older adults. My older relatives often need to steer clear of this medication because it leaves them confused for hours.
Some reactions stay rare, but they shouldn’t get ignored. Agitation, hallucinations, or even memory loss have all been documented. A few users have felt their heart racing. Anyone with a personal or family history of mental health challenges faces a higher chance of strong side effects. Young children appear more sensitive, and scopolamine gets prescribed only with extra caution for them.
Doctors always weigh the good against the bad. For most healthy adults, short-term use for travel usually stays safe with the help of basic precautions. I always remind patients to apply the patch to clean, dry skin, avoid touching their eyes (scopolamine on the fingers causes pupil changes), and never double up on patches. If problems go beyond a dry mouth or mild tiredness, it’s smart to pull the patch off and contact a doctor right away.
Prevention still works best. Traveling with snacks, staying hydrated, looking out the window, and choosing front seats reduce motion sickness. Medicines carry trade-offs, and scopolamine is no different. Knowing the side effects ahead of time helps anyone using this medication weigh the choice for themselves. By working through the options and side effects, people can travel with a little less worry.
Scopolamine hydrobromide draws plenty of interest due to its unique medical uses. Coming from the nightshade family, this compound often serves people who battle motion sickness or need help ahead of certain surgical procedures. Anytime I think of scopolamine, I picture those little patches people stick behind their ears on cruise ships. It isn’t just a travel hack—it’s a real, controlled treatment, and using it properly isn’t just about comfort. Safety comes first.
Doctors often choose a transdermal patch for reliable dosing. That patch looks small, but it packs a punch and delivers medicine over several days. Maybe you’ve seen someone rub their eyes after adjusting the patch and then complain of blurred vision—that’s because scopolamine travels fast, including through broken skin. Tablets and injections also exist, though less frequently found outside the hospital. Swallowing a pill or getting an injection brings scopolamine into the bloodstream quickly, so there’s not much room for mistakes in dosing or frequency.
The patch sits above others for convenience. You place it behind the ear on clean, hairless skin and press it firmly. One patch usually works its job for three days. It sounds simple enough, but that’s where problems can start. People often ignore the stern warnings about washing hands after application and removal. Even trace amounts of medication on your fingertips can lead to dilated pupils, confusion, or dry mouth. I learned this from a family member who rubbed her eye minutes after touching the patch and spent hours complaining about blurry vision.
Scopolamine hydrobromide works well at very defined doses. Too much, and someone might feel confused, hyperactive, or dry-mouthed for hours. Too little, and motion sickness wins. It always helps to read the instructions given by the pharmacy or healthcare provider. Some folks may try to double up if a patch falls off. That’s risky thinking—the skin still absorbs leftover medication for a while, and sticking on more can step over the line into overdose territory.
Kids, elderly people, and anyone with existing medical issues—like glaucoma, liver disease, or trouble peeing—fall into a higher-risk category. Hearing a doctor ask about eye pressure or urination may seem tedious, but they ask for good reason. It wouldn’t make sense to use scopolamine just because someone dislikes feeling queasy if it makes another health problem worse.
Always keep scopolamine out of reach of kids. Store patches and pills in a locked cabinet. Wash your hands after handling the patch. Check for side effects—especially confusion, hallucinations, or vision changes—within the first day. Reach out to a doctor if symptoms pop up. If the patch peels or falls off, discard it safely and call a healthcare professional for guidance.
Traveling often? Plan ahead. Tell your physician about other medicines and chronic conditions. And if scopolamine hydrobromide feels necessary, it’s smart to take it under direct advice, not internet tips or cruise ship folklore.
Pharmacists and health providers deal with scopolamine all the time. They know who should avoid it, the kinds of side effects to watch for, and how to handle an accidental overdose. If ever unsure, a quick call saves a lot of trouble down the line. Knowledge and respect for medication keep people safer than shortcut solutions every time.
Scopolamine hydrobromide does a real job in preventing nausea and vomiting from motion sickness. I’ve seen cruise travelers swear by its patch, and it pops up in hospitals before surgery. There’s a reason doctors write specific instructions for it. Scopolamine goes straight to the nervous system, blocking messages in the brain that trigger vomiting. That can help—until it crosses someone’s other health conditions or current medications.
The list of folks who probably shouldn’t use scopolamine isn’t small, and honestly, some might not know they’re at risk. Glaucoma stands out. I remember a family member dealing with increased eye pressure and being warned never to touch scopolamine—those with narrow-angle glaucoma can get into trouble quickly. The risk of sudden, dangerous eye pressure spikes is real.
People with enlarged prostate, urinary retention issues, or bladder obstruction get flagged, too. I once saw a urologist refuse to prescribe scopolamine to an older gentleman with trouble urinating. Not a light decision; the drug can make symptoms worse and even trigger an emergency.
Anyone with intestinal problems like pyloric stenosis or severe ulcerative colitis needs strong caution. Anticholinergic effects slow gut movement, which can worsen constipation or cause complete gut blockage in rare cases.
Heart issues matter here too. Folks living with arrhythmias, severe heart block, or fast heartbeat can find scopolamine hard on their system. Its action can tip the balance toward a rhythm problem.
Older adults face more risk, not less. The confusion, blurry vision, and balance problems that can appear with drugs like scopolamine hit seniors especially hard. There’s enough evidence in clinics: falls, memory fog, dehydration, all ramp up quickly in the older crowd.
Mix scopolamine with other drugs, and things can spiral. Combining it with other anticholinergics—think antihistamines, some psychiatric pills—leads to double or triple side effects. Those include severe dry mouth, vision changes, difficulty urinating, and sometimes scary hallucinations.
Some people end up in the ER just because their medication list wasn’t double-checked. Over-the-counter sleep aids, cold pills, tricyclic antidepressants—they all share common effects. Pharmacists, in my experience, notice these overlaps more often than most doctors, and they don’t always get looped in.
I remember cases of lightheadedness and confusion from scopolamine in people who didn’t expect it. Drivers popping a patch before a long trip find themselves weaving or struggling to focus. The drowsy feeling can last all day. That’s not small potatoes, especially on a road trip or while working with heavy machinery.
People with allergies to belladonna alkaloids must keep away from scopolamine—skin rashes or full-on anaphylactic reactions can knock someone flat.
Before starting scopolamine, sharing every medication and health concern with a doctor or pharmacist tops the list. I see too many stories where people assume it’s “just a patch.”
Short-term use, at the lowest dose, helps prevent big problems. Those who have to drive, operate equipment, or have a history of falls should consider alternatives or ask about wristbands that use acupressure.
For anyone helping an older family member, regular check-ins about new confusion or balance trouble make a difference. If symptoms appear, remove the patch and call the doctor right away. Researchers and clinicians keep track, and as more people ask for clear answers, safety improves for everyone.
Few drug names sound as mysterious as scopolamine hydrobromide, yet it’s a common tool in medicine. Used mostly for motion sickness or to control nausea after surgery, the little patch or pill can make life easier on a road trip or after anesthesia. It's tempting to see it as harmless because many of us reach for it before hopping on a boat or long-haul flight. The real story starts when scopolamine meets other medications in your system. Drug interactions often fly under the radar until someone lands in the emergency room. My own family learned this in a tough way after my grandfather used a scopolamine patch for vertigo just days after starting a new prescription for depression. Confusion set in quickly, and his usual spark almost vanished. A trip to the doctor revealed the cause: his meds didn’t play well together.
Mixing scopolamine with other common medicines can trigger unwanted side effects. Antidepressants, antihistamines, and sleeping pills top the list. These drugs often dry out your body, slow your gut, or fog up your mind. Put them together with scopolamine, and things get tricky. Facts show anticholinergic drugs work by blocking a brain chemical called acetylcholine. Use two or more at once, like scopolamine and Benadryl, and the effects add up fast—dry mouth, blurred vision, trouble peeing, constipation, dizziness, confusion. Older adults are particularly at risk. The American Geriatrics Society regularly calls out this cocktail as a cause of falls and confusion in seniors.
Even something as simple as taking scopolamine alongside a muscle relaxer or medicines for irritable bowel syndrome can ramp up the risks. People with glaucoma, heart problems, or trouble urinating face extra danger, as the combined drugs can push their bodies into overload. Emergency rooms often tell stories of patients with sudden hallucinations or rapid heartbeats who had no idea their motion sickness patch mixed poorly with other prescriptions.
Prescriptions pile up as people get older. Polypharmacy—juggling five or more medicines at once—has become common in the U.S. and beyond. Every prescription brings new risks, especially when doctors and pharmacists don’t see the full list. In my work caring for my elderly grandmother, I kept her medication list handy at every visit. On more than one occasion, flagging scopolamine as a possible troublemaker saved her a lot of distress. The CDC points out that over a million emergency visits each year happen due to drug interactions or adverse drug events, with interactions involving anticholinergic medicines being a frequent culprit.
Doctors and pharmacists urge patients to bring all their medicines—bottles included—to each checkup. This may seem tedious, but having a full picture helps spot risky combinations. Asking questions never hurts. Whenever starting scopolamine, patients can check with their pharmacist for interactions, especially if they already take medicine for mood, movement, allergies, or gut issues. Electronic health records and pharmacy apps now flag common interactions automatically, which can give extra peace of mind.
Sharing updated medication lists with every healthcare provider makes a bigger difference than most people think. Open conversations about new symptoms—such as brain fog, dry mouth, or blurred vision—often hold the clues needed to catch a lurking drug interaction before it causes harm. The more knowledge we share with our doctors, the safer our journeys, whether we’re sailing across the world or simply trying to feel better at home.
| Names | |
| Preferred IUPAC name | (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2-phenylacetate hydrobromide |
| Other names |
Hyoscine Hydrobromide Scopoderm Transderm-Scop Scopace |
| Pronunciation | /skəˈpɒləˌmiːn haɪˈdrəʊbrəˌmaɪd/ |
| Identifiers | |
| CAS Number | 6533-68-2 |
| 3D model (JSmol) | `load =C1CC2=CC=CC=C2N(C1)C(=O)OC3=CC=CC=C3.Br` |
| Beilstein Reference | 358083 |
| ChEBI | CHEBI:9070 |
| ChEMBL | CHEMBL1200774 |
| ChemSpider | 12977 |
| DrugBank | DB00747 |
| ECHA InfoCard | 100.011.567 |
| EC Number | 200-342-2 |
| Gmelin Reference | 6046 |
| KEGG | C00451 |
| MeSH | D013217 |
| PubChem CID | 164941 |
| RTECS number | GN8050000 |
| UNII | VK9N2UO2GX |
| UN number | UN3248 |
| Properties | |
| Chemical formula | C17H22BrNO4 |
| Molar mass | 440.36 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.5 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -0.3 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 7.6 |
| Basicity (pKb) | 7.81 |
| Magnetic susceptibility (χ) | -64.5e-6 cm³/mol |
| Dipole moment | 1.64 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 643.5 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | A04AD01 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes serious eye irritation, may cause drowsiness or dizziness. |
| GHS labelling | GHS07, GHS06 |
| Pictograms | GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Precautionary statements: "P201, P202, P264, P270, P280, P308+P313, P405, P501 |
| NFPA 704 (fire diamond) | NFPA 704: 2-3-0 |
| Autoignition temperature | 400°C |
| Lethal dose or concentration | LD50 (oral, rat): 310 mg/kg |
| LD50 (median dose) | LD50 (mouse, oral): 750 mg/kg |
| NIOSH | WQ2450000 |
| REL (Recommended) | 0.3 mg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Atropine Hyoscyamine Methscopolamine Ipratropium bromide Tiotropium bromide Homatropine Tropicamide |
